Combination chemotherapy with irinotecan and gemcitabine for taxane/platinum-resistant/refractory ovarian and primary peritoneal cancer: a multicenter phase I/II trial (GOGO-Ov 6).
Yoshino K, Kamiura S, Yokoi T, Nakae R, Fujita M, Takemura M, Adachi K, Wakimoto A, Nishizaki T, Shiki Y, Tsutsui T, Kanda Y, Kobayashi E, Hashimoto K, Mabuchi S, Ueda Y, Sawada K, Tomimatsu T, Kimura T.
Yoshino K, et al. Among authors: takemura m.
Cancer Chemother Pharmacol. 2017 Dec;80(6):1239-1247. doi: 10.1007/s00280-017-3468-5. Epub 2017 Oct 28.
Cancer Chemother Pharmacol. 2017.
PMID: 29080971
Clinical Trial.